Financing, Equity Capital Markets

BridgeBio Pharma, Inc.

03/20
|
$550.0 Million
Piper Sandler served as bookrunner for BridgeBio Pharma, Inc. on a convertible offering
Sub-Type
Convertible Offering
Sub-Sector
Biopharma